MAD2L1 and ovarian carcinoma: BRCA1, which is mutated in 10% of ovarian cancers, is a transcriptional regulator of MAD2 and the aberrant activity of mutant BRCA1 in ovarian cancer may lead to altered transcriptional regulation of MAD2 expression [11, 50].